Patents by Inventor Eberhard Nieschlag

Eberhard Nieschlag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism
    Publication number: 20100317631
    Abstract: The present invention relates to a gel composition on alcoholic basis, comprising at least one androgenic steroid and at least one C3-C4 diol as enhancer, as well as the use of a composition comprising at least one androgenic steroid on the scrotum for the treatment and/or prophylaxis of hypogonadism.
    Type: Application
    Filed: June 7, 2010
    Publication date: December 16, 2010
    Applicant: Dr. August Wolff GmbH & Co. Arzneimittel
    Inventors: Bernd SCHULZE, Eberhard Nieschlag
  • Male contraceptive formulation comprising norethisterone
    Publication number: 20060142257
    Abstract: A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), particularly its derivatives Norethisterone acetate and Norethisterone enanthate in sufficient doses induce oligozoospermia or azoospermia in males. Formulations further comprising an androgen, such as a testosterone derivative such as a testosterone ester, particularly testosterone undecanoate, are especially effective male contraceptive formulations.
    Type: Application
    Filed: February 17, 2006
    Publication date: June 29, 2006
    Inventors: Eberhard Nieschlag, Axel Kamischke, Michael Oettel, Alexander Ruebig, Ekkerhard Schillinger, Ursula-Friederike Habenicht
  • Male contraceptive formulation comprising norethisterone
    Patent number: 7025979
    Abstract: A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), particularly its derivatives Norethisterone acetate and Norethisterone enanthate in sufficient doses induce oligozoospermia or azoospermia in males. Formulations further comprising an androgen, such as a testosterone derivative such as a testosterone ester, particularly testosterone undecanoate, are especially effective male contraceptive formulations.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: April 11, 2006
    Assignee: Schering AG
    Inventors: Eberhard Nieschlag, Axel Kamischke, Michael Oettel, Alexander Ruebig, Ekkerhard Schillinger, Ursula-Friederike Habenicht
  • Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
    Publication number: 20040044086
    Abstract: The present invention relates to a gel composition on alcoholic basis, comprising at least one androgenic steroid and at least one C3-C4 diol as enhancer, as well as the use of a composition comprising at least one androgenic steroid on the scrotum for the treatment and/or prophylaxis of hypogonadism.
    Type: Application
    Filed: September 23, 2003
    Publication date: March 4, 2004
    Inventors: Bernd Schulze, Eberhard Nieschlag
  • Male contraceptive formulation comprising norethisterone
    Publication number: 20020103176
    Abstract: A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), particularly its derivatives Norethisterone acetate and Norethisterone enanthate in sufficient doses induce oligozoospermia or azoospermia in males. Formulations further comprising an androgen, such as a testosterone derivative such as a testosterone ester, particularly testosterone undecanoate, are especially effective male contraceptive formulations.
    Type: Application
    Filed: January 19, 2001
    Publication date: August 1, 2002
    Applicant: Schering Aktiengesellschaft
    Inventors: Eberhard Nieschlag, Axel Kamischke, Michael Oettel, Alexander Ruebig, Ekkerhard Schillinger, Habenicht Ursula-Friederike